跳至主要内容
临床试验/PACTR201912769388623
PACTR201912769388623已完成4 期

Effect of Pentoxifylline on Organ Dysfunction and Mortality in Severe Sepsis

未提供0 个研究点目标入组 100 人开始时间: 2019年12月4日最近更新:
适应症

试验速览

阶段
4 期
状态
已完成
入组人数
100

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
19 Year(s) 至 44 Year(s)(—)
性别
All

入选标准

  • 1-Adult patients with age =18 years.
  • 2-Patients with severe sepsis. The diagnosis of sever sepsis was established according to the definitions of the Surviving Sepsis Campaign (SSC) (3).
  • 3-Sepsis was due to either nosocomial pneumonia or pelvi-abdominal sepsis

排除标准

  • 1.Late septic shock at presentation with multiple organ failure.
  • 2.APACHE II score on admission >25.
  • 3.Preexisting liver cirrhosis.
  • 4.Preexisting end stage renal disease
  • 5.Pregnancy.
  • 6.History of allergy or intolerance to Pentoxifylline.
  • 7.Patient with malignancies
  • 8.Uncontrolled hemorrhage
  • 10.Previous steroid therapy
  • 11.Death within 24 hours of ICU admission

研究者

发起方
未提供

相似试验